Nutrition of children with inflammatory bowel disease
https://doi.org/10.21508/1027-4065-2020-65-5-145-151
Abstract
The article reviews the role of nutrition in the development of inflammatory bowel diseases and modern methods of diet therapy of the patients with ulcerative colitis and Crohn’s disease.
Nutrition of the patients with inflammatory bowel disease, ulcerative colitis and Crohn’s disease is considered in two aspects — as a possible trigger and as a method of therapy. On the one hand, a diet rich in fruits, vegetables with a ratio not more than 5:1 m-6:m-3 of fatty acids and a 6—12 months breastfeeding are associated with a reduced risk of developing IBD. On the other hand, a high content of trans fats, sugar, higher grade flour, as well as some dietary supplements and vitamin D deficiency are considered as predisposing factors for the development of inflammatory bowel disease. The effectiveness of complete enteral nutrition of the patients with Crohn’s disease is a weighty argument in favor of the interconnection of nutrition and inflammatory bowel disease.
About the Authors
A. A. KamalovaRussian Federation
E. R. Safina
Russian Federation
R. A. Nizamova
Russian Federation
Kazan
M. Sh. Zaynetdinova
Russian Federation
Kazan
E. M. Kvitko
Russian Federation
Kazan
References
1. Kornienko E.A. Inflammatory bowel disease in children. Moscow: Prima Print, 2014; 280. (in Russ.)
2. Martinez-Medina M., Denizot J., Dreux N., Robin F., Bil-lard E, Bonnet R. et al. Western diet induces dysbiosis with increased E coli in CEABAC10 mice, alters host barrier function favouring AIEC colonisation. Gut 2014; 63(1): 116—124. DOI: 10.1136/gutjnl-2012-304119
3. Miele E., Shamir R., Aloi M., Assa A., Braegger C, Bron-sky J. et al. Nutrition in Pediatric Inflammatory Bowel Disease. A Position Paper on Behalf of the Porto Inflammatory Bowel Disease Group of the European Society of Pediatric Gastroenterology, Hepatology and Nutrition. J Pediatr Gastroenterol Nutr 2018; 66(4): 687-708. DOI: 10.1097/MPG.0000000000001896
4. Cashman K.D., Shanahan F. Is nutrition an aetiological factor for inflammatory bowel disease. Eur J Gastroenterol Hepatol 2003; 15(6): 607-613. DOI: 10.1097/00042737-200306000-00005
5. Maconi G., Ardizzone S, Cucino C., Bezzio C, Russo A.G., Porro G.B. Pre-illness changes in dietary habits and diet as a risk factor for inflammatory bowel disease: a case-control study. World J Gastroenterol 2010; 16(34): 4297-4304. DOI: 10.3748/wjg.v16.i34.4297
6. Roberts C.L., Rushworth S.L., Richman E., Rhodes J.M. Hypothesis: increased consumption of emulsifiers as an explanation for the rising incidence of Crohn’s disease. J Crohns Colitis 2013; 7(4): 338-341. DOI: 10.1016/j.crohns.2013.01.004
7. Ardesia M., Ferlazzo G., Fries W. Vitamin D and Inflammatory Bowel Disease. BioMed Res Int 2015; 2015: 470805. DOI: 10.1155/2015/470805
8. Meeker S., Seamons A., Maggio-Price L., Paik J. Protective links between vitamin D, inflammatory bowel disease and colon cancer. World J Gastroenterol 2016; 22(3): 933—948. DOI: 10.3748/wjg.v22.i3.933
9. Nicholson I., Dalzell A.M., El-Matary W. Vitamin D as a therapy for colitis: a systematic review. J Crohns Colitis 2012; 6(4): 405-411. DOI: 10.1016/j.crohns.2012.01.007
10. Kong J., Zhang Z., Musch M.W., Ning G., Sun J., Hart J. et al. Novel role of the vitamin D receptor in maintaining the integrity of the intestinal mucosal barrier. Am J Physiol Gas-trointest Liver Physiol 2008; 294(1): 208-216. DOI: 10.1152/ajpgi.00398.2007
11. Cantorna M.T., McDaniel K., Bora S., Chen J., James J. Vitamin D, immune regulation, the microbiota, and inflammatory bowel disease Exp Biol Med (Maywood) 2014; 239(11): 1524-1530. DOI: 10.1177/1535370214523890
12. Jakobsen C., Paerregaard A., Munkholm P., Wewer V. Environmental factors and risk of developing paediatric inflammatory bowel disease - A population based study 20072009. J. Crohn’s Colitis 2013; 7(1): 79-88. DOI: 10.1016/j.crohns.2012.05.024
13. Amre D.K., D’Souza S., Morgan K., Seidman G.; Lambrette P., Grimard G. et al. Imbalances in dietary consumption of fatty acids, vegetables, and fruits are associated with risk for Crohn’s disease in children. Am J Gastroenterol 2007; 102(9): 2016-2025. DOI: 10.1111/j.1572-0241.2007.01411.x
14. D’Souza S, Levy E, Mack D., Israel D., Lambrette P, Ghadirian P. et al. Dietary patterns and risk for Crohn’s disease in children. Inflamm. Bowel Dis 2008; 14(3): 367—373. DOI: 10.1002/ibd.20333
15. Costea I., Mack, D.R., Lemaitre R.N., Israel D, Marcil V., Ahmad A. et al. Interactions between the dietary polyunsaturated fatty acid ratio and genetic factors determine susceptibility to pediatric Crohn’s disease. Gastroenterol 2014; 146(4): 929— 931. DOI: 10.1053/j.gastro.2013.12.034
16. Lev-Tzion R., Griffiths A.M., Leder O., Turner D. Omega 3 fatty acids (fish oil) for maintenance of remission in Crohn’s disease. Cochrane Database Syst Rev 2014; 28(2): CD006320. DOI: 10.1002/14651858.CD006320.pub4
17. Turner D, Steinhart A.H., Griffiths A.M. Omega 3 fatty acids (fish oil) for maintenance of remission in ulcerative colitis. Cochrane Database Syst Rev 2007; 18(3): CD006443. DOI: 10.1002/14651858.CD006443.pub2
18. Forbes A., Escher J. Hebuterne X., Ktk S., Krznaric Z, Schnei-deret S. et al. ESPEN guideline: Clinical nutrition in inflammatory bowel disease. Clin Nutr 2017; 36(2): 321—347. DOI: 10.1016/j.clnu.2016.12.027
19. Hansen T.S., Jess T., Vind I., Elkjaer M., Nielsen M.F., Gam-borg M. et al. Environmental factors in inflammatory bowel disease: a case-control study based on a Danish inception cohort. J Crohns Colitis 2011; 5(6): 577-584. DOI: 10.1016/j.crohns.2011.05.010
20. Ng S.C., Tang W., Leong R.W., Chen M., Ko Y., Studd C. et al. Environmental risk factors in inflammatory bowel disease: a population-based case-control study in Asia-Pacific. Gut 2015; 64(7): 1063-1071. DOI: 10.1136/gutjnl-2014-307410
21. Order of the Ministry of Health of the Russian Federation of August 5, 2003 N330 “On measures to improve medical nutrition in medical institutions of the Russian Federation” (with amendments and additions GARANT system: http://base.garant.ru/12132439/#ixzz6QmrgbamP (in Russ.)
22. Guo A.Y., Stevens B.W., Wilson R.G., Russell C.N., Cohen M.A., Sturgeon H.C. et al. Early life environment and natural history of inflammatory bowel diseases. BMC Gastroenterol 2014; 14: 216. DOI: 10.1186/s12876-014-0216-8
23. Vernia P., Loizos P., Di Giuseppantonio I., Amore В., Chiappi-ni А., Cannizzaro S. Dietary calcium intake in patients with inflammatory bowel disease. J Crohns Colitis 2014; 8(4): 312-317. DOI: 10.1016/j.crohns.2013.09.008
24. Kaenkumchorn T., Kesavan A. Dietary Management of Pediatric Inflammatory Bowel Disease. J Med Food 2019; 22(11): 1092-1099. DOI: 10.1089/jmf.2019.0063
25. MR 2.3.1.2432-08 Norms of physiological needs for energy and nutrients for various groups of the population of the Russian Federation https://www.rospotrebnadzor.ru/documents/details.php?ELEMENT_ID=4583 (in Russ.)
26. Lewis J.D., Albenberg L., Lee D., Kratz M., Gottlieb K., Reinisch W. The importance and challenges of dietary intervention trials for inflammatory bowel disease. Inflamm Bowel Dis 2017; 23(2): 181-191. DOI: 10.1097/MIB.0000000000001009
27. Burgis J.C., Nguyen K., Park K.T., Cox K. Response to strict and liberalized specific carbohydrate diet in pediatric Crohn’s disease. World J Gastroenterol 2016; 22(6): 2111-2117. DOI: 10.3748/wjg.v22.i6.2111
28. Obih C., Wahbeh G., Lee D., Braly K., Giefer M., Shaffer M.L. et al. Specific carbohydrate diet for pediatric inflammatory bowel disease in clinical practice within an academic IBD center. Nutrition 2016; 32(4): 418-425. DOI: 10.1016/j.nut.2015.08.025
29. Goel A., Kunnumakkara A.B., Aggarwal B.B. Curcumin as “curcumin”: From kitchen to clinic. Biochem Pharmacol 2008; 75(4): 787-809. DOI: 10.1016/j.bcp.2007.08.016
30. Hanai H., Iida T., Takeuchi K., Watanabe F., Maruyama Y., Andoh A. et al. Curcumin maintenance therapy for ulcerative colitis: Randomized, multicenter, double-blind, placebo-controlled trial. Clin Gastroenterol Hepatol 2006; 4(12): 1502-1506. DOI: 10.1016/j.cgh.2006.08.008
31. Suskind D.L., Wahbeh G., Burpee T., Cohen M., Christie D., Weber W. Tolerability of curcumin in pediatric inflammatory bowel disease: A forced-dose titration study. J. Pediatr Gastroenterol Nutr 2013; 56(3): 277-279. DOI: 10.1097/ MPG.0b013e318276977d
32. Miele E., Pascarella F., Giannetti E., Quaglietta L., Baldassa-no R.N., Staiano A. Effect of a probiotic preparation (VSL#3) on induction and maintenance of remission in children with ulcerative colitis. Am J Gastroenterol 2009; 104(2): 437-443. DOI: 10.1038/ajg.2008.118
33. Bousvaros A., Guandalini S., Baldassano R.N., Botelho C., Evans J., Ferry G.D. et al. A randomized, double-blind trial of Lactobacillus GG versus placebo in addition to standard maintenance therapy for children with Crohn’s disease. Inflamm Bowel Dis 2005; 11(9): 833-839. DOI: 10.1097/01.mib.0000175905.00212.2c
34. Shen J, Ran H.Z, Yin M.H., Zhou T.X., Xiao D.S. Meta-analysis: the effect and adverse events of Lactobacilli versus placebo in maintenance therapy for Crohn disease. Intern Med J 2009; 39(2): 103-109. DOI: 10.1111/j.1445-5994.2008.01791.x
35. Sigall-Boneh R., Pfeffer-Gik T., Segal I., Zangen T., Boaz M., Levine A. Partial enteral nutrition with a Crohn’s disease exclusion diet is effective for induction of remission in children and young adults with Crohn’s disease. In-flamm Bowel Dis 2014; 20(8): 1353-1360. DOI: 10.1097/MIB.0000000000000110
36. Levine A., Wine E., Assa A., Boneh R.S., Shaoul R., Kori M. et al. Crohn’s Disease Exclusion Diet Plus Partial Enteral Nutrition Induces Sustained Remission in a Randomized Controlled Trial. Gastroenterol 2019; 157(2): 440-450. DOI: 10.1053/j.gastro.2019.04.021
Review
For citations:
Kamalova A.A., Safina E.R., Nizamova R.A., Zaynetdinova M.Sh., Kvitko E.M. Nutrition of children with inflammatory bowel disease. Rossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics). 2020;65(5):145-151. (In Russ.) https://doi.org/10.21508/1027-4065-2020-65-5-145-151